The Drug Enforcement Administration (DEA)… authorized two cannabis companies to harvest marijuana for research purposes… ending a five-decade federal monopoly. National Institute on Drug Abuse (NIDA) director Nora Volkow told the outlet that it would be “valuable” for researchers to use marijuana from dispensaries to examine what kind of weed is being consumed to better…
When I think about the most traumatized people in our society, race is certainly a major factor, but class too is absolutely massive. So many people are stuck in real scarcity. Chronic scarcity in communities usually leads to chronic trauma, and of course that can be compounded with other forms of oppression. How can we…
…a gentrification of consciousness, a brave new world of psychedelic haves and have-nots… the gentrification of consciousness often involves stripping the journeys to altered states of all their historical, cultural, and religious significance and commodifying them in the mill of mass consumption… “The trauma we’re dealing with most is the trauma that comes from the…
Much as happened with the cannabis industry a decade ago, a culture clash is now developing between social justice activists who fought for the legalisation of psychedelics and [the] wealthy… often new to the drugs, who have the resources to dominate an emerging industry. “The idea that psychedelics should only be used to heal something…
The technocratic model of medicine… mind-body separation allows for us to subconsciously develop the idea that our bodies are property of an institution, and are reliant on medical intervention for survival. The issue of medical misogyny is one that is deeply rooted in technocratic medicine… industrialized medicine is reliant on the technocratic model, for it…
The investigators have since completed Phase II of the study… [with significant differing results from phase 1]. The research, published in The Journal of Psychopharmacology, is an essential first step in demonstrating the safety and feasibility of psilocybin [in phase 1 trials]. Original Article (Scitech daily):Psychedelic drug from magic mushrooms – psilocybin – can be safely…
…facing a holdup at the FDA in bringing its LSD program to more patients… didn’t dive into what issues the agency flagged before it made its decision. Not a whole lot is known about the New York biotech except that Barrow, formerly interim CEO and chief development officer, stepped into the full-time CEO role about…
The FDA’s move is the latest blow to the psychedelic industry’s attempts to use LSD and other compounds such as psilocybin for therapeutic purposes. Mind Medicine’s shares fell 10.4% to $1.46 before the bell. In November, shares of Compass Pathways (CMPS.O) fell roughly 16% due to safety concerns on its experimental drug COMP360, which uses…
An advisory committee of the World Health Organization (WHO) has concluded there is insufficient evidence to recommend a “critical review” of kratom, which potentially could have lead to international controls on the herbal supplement used by millions to treat pain and other medical conditions. “It is a great victory for kratom consumers, for science and…
Of those who used psychedelics, half said that their past use had a significant positive impact on their ability to cope with lockdowns, while 16 percent said it had a small impact, and 35 percent said it didn’t make a difference. Greater significant impacts were reported among those who used psychedelics regularly than those who…
Recent Comments